Aggrastat

In the US, Aggrastat (tirofiban systemic) is a member of the drug class glycoprotein platelet inhibitors and is used to treat Acute Coronary Syndrome.

US matches:

• Aggrastat

UK matches:

• Aggrastat Bag 50mcg/ml solution for Infusion (SPC)
• Aggrastat Vial 250mcg/ml Concentrate for solution for Infusion (SPC)

Ingredient matches for Aggrastat

Tirofiban

Tirofiban is reported as an ingredient of Aggrastat in the following countries:

• Barbados


• Bulgaria


• Poland

Tirofiban hydrochloride monohydrate (a derivative of Tirofiban) is reported as an ingredient of Aggrastat in the following countries:

• Aruba


• Australia


• Austria


• Bahamas


• Belgium


• Belize


• Canada


• Cayman Islands


• Croatia (Hrvatska)


• Dominican Republic


• Estonia


• Finland


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Jamaica


• Latvia


• Lithuania


• Luxembourg


• Malaysia


• Malta


• Netherlands


• Netherlands Antilles


• New Zealand


• Norway


• Philippines


• Romania


• Serbia


• Singapore


• Slovenia


• South Africa


• Sweden


• Switzerland


• Taiwan


• Thailand


• Trinidad & Tobago


• Turkey


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.